Michael R. Kurman
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Michael R. Kurman
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD.
17
| Extinct | Pharmaceuticals: Major | 17 |
| Subsidiary | Pharmaceuticals: Major | 12 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Michael R. Kurman tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
ACNielsen Corp.
 ACNielsen Corp. Miscellaneous Commercial ServicesCommercial Services ACNielsen Corp. provides market research, information and analysis services. The company was founded by Arthur C. Nielsen in 1923 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Operating Officer | |
| REVVITY, INC. | Medical Specialties | Director/Board Member | |
| AGENUS INC. | Biotechnology | Director of Finance/CFO | |
| INTERMUNE INC | Biotechnology | Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member | |
| BELLUS HEALTH | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| AVEDRO, INC. | Medical Specialties | Director of Finance/CFO | |
NeoDiagnostix, Inc.
 NeoDiagnostix, Inc. Medical/Nursing ServicesHealth Services NeoDiagnostix, Inc. operates as a cancer diagnostics company. It develops molecular diagnostic and prognostic tests for the treatment of cancer. The firm offers diagnostic testing services using genetic technologies. The company was founded by Barg Upender in 2005 and is headquartered in Gaithersburg, MD. | Medical/Nursing Services | Chairman Founder | |
Metriopharm AG
 Metriopharm AG Pharmaceuticals: MajorHealth Technology Metriopharm AG engages in the development and manufacture of pharmaceutical products. It offers pipeline, indicators and clinical trials. The company was founded by Ekkehard Brysch and Wolfgang Brysch in 2007 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chairman | |
Noble Life Sciences, Inc.
 Noble Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Noble Life Sciences, Inc. provides in vitro and in vivo preclinical drug development services. It specializes in personalized medicine and biomarker research and preclinical drug development. The company was founded by Kenneth C. Carter in 2010 and is headquartered in Sykesville, MD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
Picchio Pharma, Inc.
 Picchio Pharma, Inc. Pharmaceuticals: GenericHealth Technology Picchio Pharma, Inc. engages in acquiring, developing, and commercializing new therapeutic products and technologies. The company was founded in 2001 and is headquartered in Laval, Canada. | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Director/Board Member | |
| McGill University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree | |
| University of Western Ontario | College/University | Undergraduate Degree | |
| State University of New York at Buffalo | College/University | Doctorate Degree | |
| University of Maryland | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of Windsor | College/University | Masters Business Admin | |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Components | Director/Board Member | |
GlycoFi, Inc.
 GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Biotechnology | Chief Executive Officer | |
| Université Laval | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| THERIVA BIOLOGICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | President | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Revvity BV
 Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Medical Specialties | Director/Board Member | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
| Séminaire de Sherbrooke | College/University | Undergraduate Degree | |
| Trovis Pharmaceuticals LLC | Director of Finance/CFO | ||
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Biotechnology | Founder | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Chairman | |
| GALENICA AG | Medical Distributors | Director/Board Member | |
| CERVOMED INC. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 27 |
| Canada | 14 |
| Svizzera | 6 |
| Regno Unito | 4 |
| Danimarca | 2 |
Settori
| Health Technology | 29 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Electronic Technology | 3 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 138 |
| Corporate Officer/Principal | 57 |
| Independent Dir/Board Member | 33 |
| Chairman | 27 |
| President | 25 |
Contatti più connessi
| Insiders | |
|---|---|
| Franklin Berger | 41 |
| David Kabakoff | 30 |
| Sylvie Grégoire | 25 |
| Kenneth Carter | 18 |
| Philippe Couillard | 17 |
| Andrew Fromkin | 16 |
| Charles Ballantyne | 15 |
| Raymond J. Whitaker | 14 |
| Alan G. Walton | 13 |
| Bradley G. Lorimier | 11 |
| Gary Lessing | 10 |
| William H. Washecka | 10 |
| James H. Meade | 10 |
| François M. Legault | 9 |
| David D. Muth | 9 |
- Borsa valori
- Insiders
- Michael R. Kurman
- Connessioni Società
